276 related articles for article (PubMed ID: 25138255)
1. Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer.
Kim SY; Lee SJ; Lim SJ
Int J Pharm; 2014 Nov; 475(1-2):49-59. PubMed ID: 25138255
[TBL] [Abstract][Full Text] [Related]
2. Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer.
Kim SY; Lee SJ; Kim JK; Choi HG; Lim SJ
Int J Nanomedicine; 2017; 12():7323-7335. PubMed ID: 29070949
[TBL] [Abstract][Full Text] [Related]
3. Aminoclay as a highly effective cationic vehicle for enhancing adenovirus-mediated gene transfer through nanobiohybrid complex formation.
Kim SY; Lee SJ; Han HK; Lim SJ
Acta Biomater; 2017 Feb; 49():521-530. PubMed ID: 27872011
[TBL] [Abstract][Full Text] [Related]
4. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins.
Qiu C; De Young MB; Finn A; Dichek DA
Hum Gene Ther; 1998 Mar; 9(4):507-20. PubMed ID: 9525312
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivo.
Han SY; Lee YJ; Jung HI; Lee SW; Lim SJ; Hong SH; Jeong JS
Exp Mol Med; 2008 Aug; 40(4):427-34. PubMed ID: 18779655
[TBL] [Abstract][Full Text] [Related]
6. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
[TBL] [Abstract][Full Text] [Related]
7. Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.
Lee EM; Hong SH; Lee YJ; Kang YH; Choi KC; Choi SH; Kim IH; Lim SJ
J Cancer Res Clin Oncol; 2004 Mar; 130(3):169-77. PubMed ID: 14677059
[TBL] [Abstract][Full Text] [Related]
8. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
10. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR
Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889
[TBL] [Abstract][Full Text] [Related]
11. Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer.
Snoeys J; Mertens G; Lievens J; van Berkel T; Collen D; Biessen EA; De Geest B
Mol Ther; 2006 Jan; 13(1):98-107. PubMed ID: 16112619
[TBL] [Abstract][Full Text] [Related]
12. Cationic lipid emulsions containing heavy oils for the transfection of adherent cells.
Yoo HS; Kwon SM; Kim YJ; Chung H; Kwon IC; Kim J; Jeong SY
J Control Release; 2004 Jul; 98(1):179-88. PubMed ID: 15245899
[TBL] [Abstract][Full Text] [Related]
13. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo.
Chu Q; St George JA; Lukason M; Cheng SH; Scheule RK; Eastman SJ
Hum Gene Ther; 2001 Mar; 12(5):455-67. PubMed ID: 11268280
[TBL] [Abstract][Full Text] [Related]
14. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration.
Price AR; Limberis MP; Wilson JM; Diamond SL
Gene Ther; 2007 Nov; 14(22):1594-604. PubMed ID: 17898795
[TBL] [Abstract][Full Text] [Related]
16. Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents.
Kim TW; Chung H; Kwon IC; Sung HC; Jeong SY
Pharm Res; 2001 Jan; 18(1):54-60. PubMed ID: 11336353
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models.
Wang L; Yao B; Li Q; Mei K; Xu JR; Li HX; Wang YS; Wen YJ; Wang XD; Yang HS; Li YH; Luo F; Wu Y; Liu YY; Yang L
Hum Gene Ther; 2011 Sep; 22(9):1061-9. PubMed ID: 21615297
[TBL] [Abstract][Full Text] [Related]
18. In vivo time-dependent gene expression of cationic lipid-based emulsion as a stable and biocompatible non-viral gene carrier.
Kwon SM; Nam HY; Nam T; Park K; Lee S; Kim K; Kwon IC; Kim J; Kang D; Park JH; Jeong SY
J Control Release; 2008 May; 128(1):89-97. PubMed ID: 18384902
[TBL] [Abstract][Full Text] [Related]
19. A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver.
Tietge UJ; Kozarsky KF; Donahee MH; Rader DJ
J Gene Med; 2003 Jul; 5(7):567-75. PubMed ID: 12825196
[TBL] [Abstract][Full Text] [Related]
20. Localized adenovirus gene delivery using antiviral IgG complexation.
Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
